Privatklinik Meiringen
Meiringen, Switzerland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationReimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
- ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
- Phone+41 33 972 81 11
- Websitehttps://www.privatklinik-meiringen.ch
About this provider
Privatklinik Meiringen is a private psychiatric clinic in the Bernese Oberland (Willigen, Meiringen) with core competencies in depression, alcohol and medication dependence and stress-related illness/burnout. Among its extended therapy procedures it explicitly offers ketamine therapy: intravenous and nasal ketamine as well as S-ketamine (Swissmedic-approved since 2020) for patients with treatment-resistant depression, with close monitoring and careful medical assessment of the indication; the same programme mentions participation options in a multicenter study of oral extended-release ketamine. The clinic also runs centres for old-age psychiatry, behavioural addictions and burnout.
Services & programs
- Ketamine therapy (intravenous and nasal) and S-ketamine for treatment-resistant depression
- Extended therapy procedures programme
- Inpatient treatment of depression, alcohol and medication dependence
- Centre for stress-related illness/burnout
- Centre for behavioural addictions
- Centre for old-age psychiatry
- Psychiatry centre for young adults (PZJE Thun)
- Outpatient services and mother-child care option
Common questions
Who decides whether I can receive ketamine or esketamine at Privatklinik Meiringen?
Per the clinic, the indication is carefully assessed and weighed by its physicians, and treatments are closely monitored; a named senior physician is listed as contact via the main line +41 33 972 81 11. Referral by your treating psychiatrist is the standard route.
What insurance conditions apply for the nasal spray (Spravato)?
Under the BAG Limitatio, basic insurance covers esketamine nasal spray for adults 18-74 with treatment-resistant depression (at least two antidepressants with different mechanisms plus one augmentation attempt failed, confirmed severity) only after the insurer's cost approval (Kostengutsprache), for a maximum of 10 months.
Verification
- License / registryBAG SL Limitatio
- Sourcehttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
- Last verified